Additionally, RT‐qPCR analysis indicated that CHST9 was expressed at low levels in tumour samples, while HMGN4, ITGAV, RAP2A, TMCO3, and ZFYVE26 displayed high expression levels (Figure 11B). This evidence concerns the gene CHST9 and neoplasm.